Clinical Trials in Detroit

Showing 12041-12060 of 19,719 trials

Mitroflow DL Post Approval Study- North America

NCT02351726

Prospective, non-randomized, multicenter post-approval study to collect long term clinical and echographic data on Mitroflow DL patients.

Aortic StenosisAortic RegurgitationAortic Valve Insufficiency+6 more

LivaNova186 participantsStarted Mar 2015

Los Angeles, California, United States • San Diego, California, United States • Jacksonville, Florida, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

NCT00979992

This phase II trial studies the side effects of sunitinib malate and how well it works in treating patients with ovarian cancer that is persistent or has come back. Sunitinib malate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor.

Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma

National Cancer Institute (NCI)35 participantsStarted Apr 2010

Birmingham, Alabama, United States • Burbank, California, United States • Concord, California, United States +94 more locations

Mitroflow DL Post Approval Study- North America

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Find Trials by Condition in Detroit

Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and Effectiveness

A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)

A Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia Analyzed by Biopsy of the Scalp Prior To and Post Dosing

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the Pancreas

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis

A Comparison of Two Socket Sealing Collagen Matrices for Extraction Socket Management

Clazosentan in Reducing Vasospasm-related Morbidity and All-cause Mortality in Adult Patients With Aneurysmal Subarachnoid Hemorrhage Treated by Surgical Clipping

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

Long Term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Post-Approval Prospective Study - Conventus CAGE™ PH for Use in Proximal Humerus Fracture Fixation

Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat